SerenQ LL-37 6mg Peptide Pen

SerenQ LL-37 6mg Peptide Pen
SerenQ Pharmaceuticals

SerenQ LL-37 6mg Peptide Pen

LL-37 · 预充注射笔 · 6mg
Out of Stock 缺货 -29% ✓ 批次可追溯 ✓ 第三方 COA 检测
£60.00
Currently unavailable
🚚 UK 境内配送 · 冷链/避光包装
前往购买 / 询价

Specifications 规格参数

含量规格 Content 6mg
剂型 Format 预充注射笔
总容量 Total volume 3 ml
浓度 Concentration 2.00 mg/ml
针头规格 Pen tips 32G 0.23 x 4mm
活性成分 Ingredient LL-37
CAS 号 154947-66-7

About the Product 产品详情

UK Launch · The Ped Shop Exclusive

A new name in research peptides, landing in the UK

SerenQ Pharmaceuticals builds research peptides into sealed, pre-filled injection pens rather than lyophilised vials. No reconstitution, no bacteriostatic water, no guesswork with a syringe barrel. Dial the units you need, read them off the window, done.

SerenQ has appointed

The Ped Shop as its exclusive UK stockist

. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.

SerenQ Pharmaceuticals

LL-37

Peptide Injection Pen System

Content

LL-37 6mg

Dial graduation

10u = 200mcg

Per unit

Total units

Format

Pre-filled pen

Pen tips

32G 0.23 x 4mm

Expiry

12/2027

Authenticity

QR + serial

Composition & Dosing Guide

LL-37 6mg · 3 ml pen · 300 units

Total volume

3 ml

Total liquid in the pen

Total contents

6 mg

LL-37 in the pen

Dosing scale

0.01 ml = 1 unit

Each unit on the pen dial equals 0.01 ml

Concentration

2.00 mg/ml

LL-37 per millilitre

Dosing examples

Units

Volume (ml)

LL-37 (mg)

| 2 units

| 0.02 ml

| 0.04 mg

| 4 units

| 0.04 ml

| 0.08 mg

| 6 units

| 0.06 ml

| 0.12 mg

| 8 units

| 0.08 ml

| 0.16 mg

| 10 units

| 0.10 ml

| 0.20 mg

| 12 units

| 0.12 ml

| 0.24 mg

| 14 units

| 0.14 ml

| 0.28 mg

| 16 units

| 0.16 ml

| 0.32 mg

| 18 units

| 0.18 ml

| 0.36 mg

| 20 units

| 0.20 ml

| 0.40 mg

| …

| 300 units

| 3.00 ml (full pen)

| 6.00 mg (total)

Key example

10 units = 0.10 ml

, the pen’s dial graduation, containing 0.20 mg LL-37.

Figures are the pen’s stated contents divided across its 300 units. For research purposes only. Not for human consumption.

Third Party Testing

Results pending

Every SerenQ batch is sent for independent analysis before it goes on general sale. Purity and identity testing for this batch is currently with

Analiza

, and the certificate will be published on this page the moment it lands.

Laboratory

Analiza

Test

Purity & identity

Method

HPLC / MS

Status

Awaiting report

Check back here for the full certificate, or ask us and we will send it over as soon as it is released.

Serialised & QR Verified

Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.

One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag.

You can verify your SerenQ authenticity and view the latest HPLC at

About LL-37

LL-37 is the only human cathelicidin, a 37 amino acid antimicrobial peptide cleaved from the precursor protein hCAP18. It is produced by neutrophils, epithelial cells and keratinocytes, and forms part of the innate immune system: the fast, non-specific defence layer that acts before adaptive immunity has identified anything.

Its primary described action is direct membrane disruption of bacteria, which is a mechanical rather than a biochemical kill and is the reason resistance to it is uncommon. Beyond that, the research literature describes it as immunomodulatory rather than simply antimicrobial: it influences chemotaxis, neutralises bacterial endotoxin, and appears in work on wound closure and angiogenesis.

It has a genuinely two sided profile, and this is worth understanding before choosing it. The same peptide that closes wounds is implicated in the pathology of rosacea and psoriasis, where excess LL-37 in the skin drives inflammation rather than resolving it. It is not a compound where more is straightforwardly better.

Where the evidence sits:

LL-37 is well characterised as an endogenous human peptide and there is a substantial basic science literature on it. Clinical work using it as an administered therapeutic is early stage and narrow, mostly topical and in specific wound types. Its implicated role in inflammatory skin disease is documented. It holds no medicines licence.

The pen format

Doses in the LL-37 literature are small relative to the pen, which is exactly the case where a 20mcg dial step earns its keep. 6mg across 300 units gives fine control at the low end.

6.00mg of LL-37

per pen, in solution and ready to use

1 unit = 20mcg.

10 units on the dial gives 200mcg

300 units in total

, which works out at 30 full 200mcg draws per pen

– Dial and dose window let you set the exact amount and read it back before dispensing

– 4 screw on pen tips supplied, individually sealed,

32G 0.23 x 4mm

– Protective cap, clip and a rigid retail carton for storage and transport

– Batch number, expiry and serial printed directly on the pen barrel, not just the box

Handling and storage

– Store refrigerated at 2 to 8°C. Do not freeze

– Keep in the outer carton, away from direct light

– Short periods at room temperature during transit are expected and normal

– Use a fresh sealed tip for each dispense and dispose of tips in a sharps container

– Expiry 12/2027 on sealed, correctly stored stock

– Keep out of reach of children and animals

What is in the box

– 1 × SerenQ LL-37 6mg pre-filled injection pen

– 4 × sealed pen tips, 32G 0.23 x 4mm

– Serialised, QR coded retail carton

Choosing between LL-37, Thymosin Alpha-1 and KPV

These three get filed together as immune peptides and they do quite different things. LL-37 is innate immunity: direct antimicrobial action plus modulation of the inflammatory response.

Thymosin Alpha-1

works on the adaptive side, on T cell maturation and dendritic cell function, and has by far the strongest clinical record of the three, including licensed use in several countries.

KPV

is the tripeptide tail of alpha-MSH and is purely anti-inflammatory, with no antimicrobial activity at all. Where LL-37 can push inflammation in either direction depending on context, KPV only damps it, which makes it the more predictable choice when suppression is the goal.

Guides that

Third-Party Testing 第三方检测

检测机构 LaboratoryAnaliza Białek
检测方法 MethodHPLC

What's in the Box 包装清单

  • 1 × 预充注射笔
  • 配套密封笔尖(数量以供应商包装为准)

Usage 使用说明

  • 每次使用更换全新密封笔尖
  • 旋拧刻度并核对剂量窗口
  • 按研究方案设定的剂量给药

Handling & Storage 储存条件

  • 2-8°C 冷藏,勿冷冻
  • 避光保存于原包装盒内
  • 首次启用后按供应商建议的期限内使用

Applications 应用方向

LL-37 免疫调节

For research purposes only 免责声明

本条目信息整理自公开销售页面(The Ped Shop),仅供研究与信息参考。所列产品按研究用途展示,不作为药品或保健品销售,不用于诊断、治疗、治愈或预防任何疾病。实际规格、价格与库存以供应商页面为准。

UK Launch · The Ped Shop Exclusive

A new name in research peptides, landing in the UK

SerenQ Pharmaceuticals builds research peptides into sealed, pre-filled injection pens rather than lyophilised vials. No reconstitution, no bacteriostatic water, no guesswork with a syringe barrel. Dial the units you need, read them off the window, done.

SerenQ has appointed

The Ped Shop as its exclusive UK stockist

. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.

SerenQ Pharmaceuticals

LL-37

Peptide Injection Pen System

Content

LL-37 6mg

Dial graduation

10u = 200mcg

Per unit

Total units

Format

Pre-filled pen

Pen tips

32G 0.23 x 4mm

Expiry

12/2027

Authenticity

QR + serial

Composition & Dosing Guide

LL-37 6mg · 3 ml pen · 300 units

Total volume

3 ml

Total liquid in the pen

Total contents

6 mg

LL-37 in the pen

Dosing scale

0.01 ml = 1 unit

Each unit on the pen dial equals 0.01 ml

Concentration

2.00 mg/ml

LL-37 per millilitre

Dosing examples

Units

Volume (ml)

LL-37 (mg)

| 2 units

| 0.02 ml

| 0.04 mg

| 4 units

| 0.04 ml

| 0.08 mg

| 6 units

| 0.06 ml

| 0.12 mg

| 8 units

| 0.08 ml

| 0.16 mg

| 10 units

| 0.10 ml

| 0.20 mg

| 12 units

| 0.12 ml

| 0.24 mg

| 14 units

| 0.14 ml

| 0.28 mg

| 16 units

| 0.16 ml

| 0.32 mg

| 18 units

| 0.18 ml

| 0.36 mg

| 20 units

| 0.20 ml

| 0.40 mg

| …

| 300 units

| 3.00 ml (full pen)

| 6.00 mg (total)

Key example

10 units = 0.10 ml

, the pen’s dial graduation, containing 0.20 mg LL-37.

Figures are the pen’s stated contents divided across its 300 units. For research purposes only. Not for human consumption.

Third Party Testing

Results pending

Every SerenQ batch is sent for independent analysis before it goes on general sale. Purity and identity testing for this batch is currently with

Analiza

, and the certificate will be published on this page the moment it lands.

Laboratory

Analiza

Test

Purity & identity

Method

HPLC / MS

Status

Awaiting report

Check back here for the full certificate, or ask us and we will send it over as soon as it is released.

Serialised & QR Verified

Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.

One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag.

You can verify your SerenQ authenticity and view the latest HPLC at

About LL-37

LL-37 is the only human cathelicidin, a 37 amino acid antimicrobial peptide cleaved from the precursor protein hCAP18. It is produced by neutrophils, epithelial cells and keratinocytes, and forms part of the innate immune system: the fast, non-specific defence layer that acts before adaptive immunity has identified anything.

Its primary described action is direct membrane disruption of bacteria, which is a mechanical rather than a biochemical kill and is the reason resistance to it is uncommon. Beyond that, the research literature describes it as immunomodulatory rather than simply antimicrobial: it influences chemotaxis, neutralises bacterial endotoxin, and appears in work on wound closure and angiogenesis.

It has a genuinely two sided profile, and this is worth understanding before choosing it. The same peptide that closes wounds is implicated in the pathology of rosacea and psoriasis, where excess LL-37 in the skin drives inflammation rather than resolving it. It is not a compound where more is straightforwardly better.

Where the evidence sits:

LL-37 is well characterised as an endogenous human peptide and there is a substantial basic science literature on it. Clinical work using it as an administered therapeutic is early stage and narrow, mostly topical and in specific wound types. Its implicated role in inflammatory skin disease is documented. It holds no medicines licence.

The pen format

Doses in the LL-37 literature are small relative to the pen, which is exactly the case where a 20mcg dial step earns its keep. 6mg across 300 units gives fine control at the low end.

6.00mg of LL-37

per pen, in solution and ready to use

1 unit = 20mcg.

10 units on the dial gives 200mcg

300 units in total

, which works out at 30 full 200mcg draws per pen

– Dial and dose window let you set the exact amount and read it back before dispensing

– 4 screw on pen tips supplied, individually sealed,

32G 0.23 x 4mm

– Protective cap, clip and a rigid retail carton for storage and transport

– Batch number, expiry and serial printed directly on the pen barrel, not just the box

Handling and storage

– Store refrigerated at 2 to 8°C. Do not freeze

– Keep in the outer carton, away from direct light

– Short periods at room temperature during transit are expected and normal

– Use a fresh sealed tip for each dispense and dispose of tips in a sharps container

– Expiry 12/2027 on sealed, correctly stored stock

– Keep out of reach of children and animals

What is in the box

– 1 × SerenQ LL-37 6mg pre-filled injection pen

– 4 × sealed pen tips, 32G 0.23 x 4mm

– Serialised, QR coded retail carton

Choosing between LL-37, Thymosin Alpha-1 and KPV

These three get filed together as immune peptides and they do quite different things. LL-37 is innate immunity: direct antimicrobial action plus modulation of the inflammatory response.

Thymosin Alpha-1

works on the adaptive side, on T cell maturation and dendritic cell function, and has by far the strongest clinical record of the three, including licensed use in several countries.

KPV

is the tripeptide tail of alpha-MSH and is purely anti-inflammatory, with no antimicrobial activity at all. Where LL-37 can push inflammation in either direction depending on context, KPV only damps it, which makes it the more predictable choice when suppression is the goal.

Guides that

登录

注册

重设密码

请输入您的用户名或电子邮箱地址。您会收到一封包含创建新密码链接的电子邮件。